Duodenocaval fistula after bevacizumab therapy: case presentation and complete overview of the literature

Duodenocaval fistula (DCF) is a very rare condition and is associated with a 41.1% of mortality rate. Although ingested foreign bodies, peptic ulcer disease and radiotherapy are often the etiologies described, only three patients have been described who developed DCF after bevacizumab therapy. We re...

Descripción completa

Detalles Bibliográficos
Autores principales: Giordano, Alessio, Moroni, Francesco, Gosmar, Alessandra, Passagnoli, Federico, Jeong, Juhye, Menici, Francesco, Baraghini, Maddalena, Mirasolo, Vita M, Campiglia, Laura, Michelagnoli, Stefano, Cantafio, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257793/
https://www.ncbi.nlm.nih.gov/pubmed/37309550
http://dx.doi.org/10.1093/jscr/rjad329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257793/
https://www.ncbi.nlm.nih.gov/pubmed/37309550
http://dx.doi.org/10.1093/jscr/rjad329

Ejemplares similares